Clinical study of the Immunoglobululin Enhancing effect of Bala compound on Infants

摘要

Kaumarbhritya a branch of Asthanga Ayurveda deals with neonatal, infant and child health care. Multicentric studies conducted in various developed and developing countries have indicated that Infant Mortality Rate (I.M.R.) is very high in developing countries, and infection has been observed as the major cause. Immune system in neonates is not yet fully functional. Bala compound having the ingredients of >Atibala (Abutilon indicum Linn), >Amalaki (Emblica officinalis Linn), >Vidanga (Emblica ribes burn), >Guduchi (Tinospora cordifolia Welld Miers), >Pippali (Piperlongum linn), >Yashtimadhu (Glycyrrhiza glabra Linn), >Shankhapuspi (Convolvulus pluricaulis Chois ), >Vacha (Acorus calamus Linn), >Musta (Cyperus rotundus Linn) and >Ativisha (Aconitum heterophyllum wall) are Medhya as well as Rasayana drugs mention in Ayurvedic classics. ‘Bala compound” was tried in infants in the form of oral drops for a period of six months and result was assessed for serum immuoglobulins IgG, IgM, IgA for three months of interval of two follow ups (i.e., third and six month of infant). There is significant increase of immunoglobulins observed after six months administration of ‘Bala compoumd”